← Leaderboards
Anthony S Bonavia
Pennsylvania State Univ Hershey Med Ctr
$1,874,686
Attributed
$1,874,686
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $433.3K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,874,686 · 2
By mechanism
R35$1,270,338 · 1
K08$604,348 · 1
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- David T Mauger$71,725,717
- Jonathan Foulds$10,738,186
Others in their field
Other Emerging Leaders on “Prognostic”
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$16,263,760
- Nadine Georges Rouphael · Emory University$13,919,512
- Quy Phung · Leidos Biomedical Research, Inc.$12,889,396
- James Dale Berry · Brigham And Women'S Hospital$9,915,782
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
Research focus
PrognosticProspectiveMortalitySepsisSyndromeAcuteImmuneInflammationPre-Clinical ModelResponseSeptic PatientsCytokineAffectFunctional DisorderCritical IllnessCellsCessation Of LifeImmune System DiseasesNational Institute Of General Medical SciencesPhenotypeScientistHealth Care CostsCaringEpidemic
Grant awards (7)
Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients$418,500
R35 · FY2025 · GM · contact PI
Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients$418,500
R35 · FY2024 · GM · contact PI
Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients$14,838
R35 · FY2024 · GM · contact PI
Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients$418,500
R35 · FY2023 · GM · contact PI
Resistin-induced immunosuppression increases susceptibility to infectious lung injury and sepsis during AKI$201,617
K08 · FY2022 · GM · contact PI
Resistin-induced immunosuppression increases susceptibility to infectious lung injury and sepsis during AKI$201,576
K08 · FY2021 · GM · contact PI
Resistin-induced immunosuppression increases susceptibility to infectious lung injury and sepsis during AKI$201,155
K08 · FY2020 · GM · contact PI